Disclosure Nature

Regulatory filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, submitting summary of proceedings of the 41st Annual General Meeting.

Meeting Details

The 41st Annual General Meeting of Concord Biotech Limited was held on Friday, July 31, 2026, at 12:00 Noon (IST) through Video Conferencing/Other Audio-Visual Means. The meeting commenced at 12:00 Noon and concluded at 12:38 PM, lasting 38 minutes.

Attendance

Total 38 members attended the meeting. Requisite quorum was present, and the meeting was declared to be in order.

Directors and Officials Present

  • Mr. Sudhir Vaid - Chairman and Managing Director
  • Mr. Ankur Vaid - Joint Managing Director & CEO
  • Mr. Ravi Kapoor - Director
  • Mr. Rajiv Agarwal - Director and Chairman of Stakeholders' Relationship Committee
  • Mr. Amitabh Thakore - Independent Director and Chairman of Audit Committee & Nomination and Remuneration Committee
  • Mr. Arvind Agarwal - Independent Director
  • Mrs. Bharti Khanna - Independent Director
  • Mr. Jayaram Easwaran - Independent Director
  • Mr. M. Sriraman - Independent Director
  • Mrs. Ekta Gupta - Independent Director
  • Mr. Raviraj Karia - Chief Financial Officer
  • Mr. Prakash Sajnani - AVP – Finance
  • Mr. Rupen Shah - Partner, B S R & Co. LLP (Statutory Auditors)
  • Mr. Ashish Shah - Secretarial Auditor and Scrutiniser

Meeting Proceedings

Mr. Paritosh Trivedi, Company Secretary & Compliance Officer, welcomed shareholders and informed about the availability of Register of Directors and Key Managerial Personnel and their Shareholding, and Register of Contracts and Arrangements for electronic inspection during the meeting.

Mr. Sudhir Vaid, Chairman & Managing Director, addressed shareholders with a speech providing an overview of operations and financial performance for the financial year ended March 31, 2026, including future prospects.

Mr. Paritosh Trivedi briefed members on the business proposed to be transacted as set out in the Meeting Notice. Members who had not exercised voting rights through remote evoting were requested to cast votes through e-voting facility during the AGM.

With members' consent, the Notice convening the 41st AGM and Directors' Report were taken as read, having been previously circulated.

Audit Reports

The Statutory Auditors' Report and Secretarial Audit Report contained no qualification, reservation, adverse remark, or disclaimer. Both reports were taken as read and placed on record.

Shareholder Interaction

Registered shareholders were invited to address the meeting and raise queries or offer comments. Management provided satisfactory responses to all queries raised.

Voting Results Timeline

Voting results along with Scrutinizer's Report were scheduled to be declared within two working days from conclusion of the AGM. Results will be hosted on company website and simultaneously submitted to CDSL and Stock Exchanges in compliance with Companies Act, 2013 and SEBI LODR Regulations, 2015.

Conclusion

The meeting concluded with expressions of gratitude to shareholders for participation and continued support, and thanks to Statutory Auditors, Secretarial Auditor, RTA, CDSL team, and all others associated with conducting the meeting.